首页> 美国卫生研究院文献>Medical Devices (Auckland N.Z.) >Barriers to medical device innovation
【2h】

Barriers to medical device innovation

机译:医疗器械创新的障碍

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The US Food and Drug Administration (FDA) has defined a medical device as a health care product that does not achieve it’s purpose by chemical action or by being metabolized. This means that a vast number of products are considered medical devices. Such devices play an essential role in the practice of medicine. The FDA classifies medical devices in three classes, depending on the risk of the device. Since Class I and II devices have relatively simple requirements for getting to the market, this review will focus on “implantable devices”, which, in general, belong to Class III. The European Union and Canada use a slightly different classification system. While early generations of medical devices were introduced without much testing, either technical or clinical, the process of introducing a Class III medical device from concept to clinical practice has become strongly regulated and requires extensive technological and clinical testing. The modern era of implantable medical devices may be considered to have started in the 1920s with development of artificial hips. The implantable pacemaker was another milestone and pacemakers and cardioverters/defibrillators have since saved millions of lives and created commercial giants in the medical device industry. This review will include some examples of cardiovascular devices. Similar considerations apply to the total implantable device market, although clinical and technological applications obviously vary considerably.
机译:美国食品药品监督管理局(FDA)将医疗设备定义为一种保健产品,该产品无法通过化学作用或代谢来达到其目的。这意味着大量产品被认为是医疗设备。这种设备在医学实践中起着至关重要的作用。 FDA根据医疗器械的风险将其分为三类。由于I类和II类设备对进入市场具有相对简单的要求,因此,本文将重点介绍通常属于III类的“可植入设备”。欧盟和加拿大使用稍微不同的分类系统。尽管引入了早期的医疗设备,但没有经过大量的技术或临床测试,但从概念到临床实践中引入III类医疗设备的过程已受到严格监管,并需要进行广泛的技术和临床测试。植入式医疗设备的现代时代可以认为是在1920年代随着人工髋关节的发展而开始的。植入式起搏器是另一个里程碑,起搏器和心脏复律器/除颤器自此挽救了数百万人的生命,并创造了医疗器械行业的商业巨头。这篇评论将包括一些心血管设备的例子。尽管临床和技术应用明显不同,但类似的考虑也适用于整个可植入设备市场。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号